Abu Dhabi: Burjeel Holdings today announced a strategic partnership with Hippocratic AI, the company that pioneered the first safety-focused generative AI healthcare agents, to transform healthcare delivery through safe, scalable, and empathetic AI. The initiative kicked off during the Abu Dhabi Global Healthcare Week.
According to Emirates News Agency, the collaboration will see Hippocratic AI’s generative AI healthcare agents, built for patient-facing non-diagnostic clinical tasks, deployed across Burjeel Holdings’ hospitals, medical centres, and physiotherapy clinics in the UAE and Oman. By integrating Hippocratic AI’s AI capabilities, Burjeel Holdings aims to transform the patient engagement experience, providing personalised and compassionate clinical conversations that address patient needs. Their introduction aligns with the Group’s commitment to integrating advanced technology in healthcare while maintaining a human-centric approach.
John Sunil, Group Chief Executive Officer of Burjeel Holdings, expressed that the future of healthcare lies in the harmony between technology and personalised care. Their partnership with Hippocratic AI aims to improve patient experience, efficiency, reduce wait times, and enhance health outcomes.
Hippocratic AI’s agents are designed to engage in natural, safety-focused, human-like conversations. Through integration, Burjeel Holdings will deliver real-time, culturally aware support across various patient touchpoints, including appointment scheduling, patient education, health risk assessments, and follow-up check ins. These agents are capable of sustained, multi-turn dialogue, providing consistent, compliant, and compassionate communication that enhances patient experience and care continuity.
Munjal Shah, Co-Founder and CEO of Hippocratic AI, highlighted the partnership’s goal of achieving healthcare abundance. Their empathic genAI agents aim to create a more compassionate and effective patient experience, with solutions tailored to the specific needs of the communities served.
Key highlights include deploying multilingual AI agents, such as Arabic and the Emirati dialect, ensuring effective communication with the region’s patient population. The collaboration will deliver customised regional generative AI agents for cultural alignment and local relevance, enhancing the quality and empathy of patient interactions. AI agents will be deployed across specialities like oncology, cardiology, neurology, and orthopaedics, supporting clinical and administrative tasks to streamline operations and elevate patient experience.
The partnership focuses on expanding these genAI healthcare agents’ deployment across Burjeel Holdings’ facilities, ensuring healthcare providers access the latest advancements in technology and patient support. This collaboration reflects a shared vision: harnessing safety-focused generative AI to ease staffing challenges and deliver hyper-personalised, compassionate care, advancing the goal of healthcare abundance.